Why did oil prices surge after Israel's strike on Iran?
How will the Nippon Steel-US Steel merger impact the steel industry?
What caused the S&P 500 to drop amid Middle East tensions?
Why is Amazon investing in nuclear power for AWS?
How is AI affecting hiring practices at Chipotle?
What are the implications of Walmart and Amazon exploring stablecoins?
Why was US Senator Alex Padilla forcibly removed from press event?
FDA Approves UroGen's Zusduri As First Drug For Recurrent Bladder Cancer
benzinga.com/news/fda/25/06/45928053/fda-approves-urogens-zusduri-as-first-drug-for-recurrent-bladder-cancer
The U.S. Food and Drug Administration (FDA) on Thursday approved UroGen Pharma Ltd.’s (NASDAQ:URGN) Zusduri, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).
Zusduri consists of mitomycin…
This story appeared on benzinga.com, 2025-06-13 14:53:59.